Found: 33
Select item for more details and to access through your institution.
Mind the gap? The platform trial as a working environment.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Germline variation in RASAL2 may predict survival in patients with RAS‐activated colorectal cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2023, v. 62, n. 6, p. 332, doi. 10.1002/gcc.23133
- By:
- Publication type:
- Article
Laparoscopic Cholecystectomy: Incidental Carcinoma of the Gallbladder with Abdominal Wall and Axillary Node Metastasis.
- Published in:
- HPB Surgery, 1997, v. 10, n. 3, p. 169, doi. 10.1155/1997/60975
- By:
- Publication type:
- Article
A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 10, p. 2384, doi. 10.1002/1878-0261.12764
- By:
- Publication type:
- Article
The prognostic utility of pre‐treatment neutrophil‐to‐lymphocyte‐ratio (NLR) in colorectal cancer: A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 17, p. 5983, doi. 10.1002/cam4.4143
- By:
- Publication type:
- Article
The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49952-x
- By:
- Publication type:
- Article
Does student teaching harm or help cancer patients?
- Published in:
- 2005
- By:
- Publication type:
- Other
Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand‐foot syndrome.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 6, p. 957, doi. 10.1002/ijc.34046
- By:
- Publication type:
- Article
Genome‐wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 9, p. 1713, doi. 10.1002/ijc.33739
- By:
- Publication type:
- Article
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units.
- Published in:
- Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-022-06680-4
- By:
- Publication type:
- Article
Severe Prolonged Immunosuppression following Fludarabine and Rituximab Combination Therapy.
- Published in:
- Chemotherapy (0009-3157), 2008, v. 54, n. 3, p. 242, doi. 10.1159/000140469
- By:
- Publication type:
- Article
Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer.
- Published in:
- JAMA Network Open, 2019, v. 29, p. e1911750, doi. 10.1001/jamanetworkopen.2019.11750
- By:
- Publication type:
- Article
Combining Oncolytic Adenovirus with Radiation--A Paradigm for the Future of Radiosensitization.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00153
- By:
- Publication type:
- Article
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT.
- Published in:
- Efficacy & Mechanism Evaluation (EME), 2022, v. 9, n. 9, p. vii, doi. 10.3310/HTNB6908
- By:
- Publication type:
- Article
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00318-z
- By:
- Publication type:
- Article
Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.
- Published in:
- Scientific Reports, 2015, p. 12372, doi. 10.1038/srep12372
- By:
- Publication type:
- Article
A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.
- Published in:
- Scientific Reports, 2015, p. 10442, doi. 10.1038/srep10442
- By:
- Publication type:
- Article
Exome Resequencing Identifies Potential Tumor-Suppressor Genes that Predispose to Colorectal Cancer.
- Published in:
- Human Mutation, 2013, v. 34, n. 7, p. 1026, doi. 10.1002/humu.22333
- By:
- Publication type:
- Article
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article
HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Re: Role of the Oxidative DNA Damage Repair Gene OGG1 in Colorectal Tumorigenesis.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Response.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Role of the Oxidative DNA Damage Repair Gene OGG1 in Colorectal Tumorigenesis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 16, p. 1249, doi. 10.1093/jnci/djt183
- By:
- Publication type:
- Article
TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15000-w
- By:
- Publication type:
- Article
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer.
- Published in:
- Clinical Trials, 2022, v. 19, n. 2, p. 146, doi. 10.1177/17407745211069879
- By:
- Publication type:
- Article
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols.
- Published in:
- Clinical Trials, 2017, v. 14, n. 5, p. 451, doi. 10.1177/1740774517725697
- By:
- Publication type:
- Article
FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article